-16.1%
CPRT vs MRNA
-67.9%
+51.7%
-57.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.6% | +5.4% | -8.0% | -2.9% |
| 7D | -11.2% | -1.1% | -10.1% | -11.1% |
| 30D | +3.3% | +126.1% | -122.8% | -6.2% |
| 3M | -3.6% | +190.0% | -193.6% | -14.8% |
| 6M | -15.8% | +157.2% | -173.0% | -25.0% |
| YTD | -23.5% | +388.2% | -411.7% | -36.3% |
| 1Y | -38.8% | +467.0% | -505.8% | -50.1% |
| 3Y | -33.4% | +36.1% | -69.5% | -39.4% |
| All | -16.1% | -67.9% | +51.7% | -15.8% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling